权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The Cysteinyl Leukotriene E4 Receptor, GPR99, Orchestrates Airway Epithelial Cell Differentiation and Type 2 Pulmonary Inflammation

半胱氨酰白三烯 E4 受体 GPR99 协调气道上皮细胞分化和 2 型肺部炎症

基本信息

批准号：
10199953
负责人：
Lora Bankova
金额：
$ 13.66万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-07-01 至 2022-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10199953
关键词：
Affinity Airway Disease Allergens Allergic Disease Alternaria Aspirin Asthma Automobile Driving Award Basophils Bioinformatics Biological Biology Bronchoconstriction Brush Cell Cell Count Cell Differentiation process Cell physiology Cells Complement Data Development Development Plans Environment Eosinophilia Epithelial Epithelial Cells Event Five-Year Plans Funding Future Gene Expression Profile Generations Genes Genetic Transcription Genomics Goals Goblet Cells Grant Hospitals Human Hypersensitivity Imaging Techniques Immune Immunity Immunology Inflammation Inflammatory Response Inhalation Interleukin-13 Intestines Knowledge Laboratories Lead Leadership Leukotriene E4 Light Liquid substance Lung Lung Inflammation Lymphoid Cell Mediating Mediator of activation protein Mentorship Metaplasia Metaplastic Cell Methods Modeling Molds Molecular Mucins Mucous Membrane Mus Nose Patients Pharmacology Physicians Population Positioning Attribute Process Production Pulmonary Inflammation Reporter Reporting Research Research Personnel Resistance Resources Role Scientist Secure Severities Signal Transduction Source Structure of mucous membrane of nose Surface Systems Biology TSLP gene Techniques Testing Therapeutic Time Tissues Training Translational Research United States National Institutes of Health Up-Regulation Update Virus Woman Work Writing airborne allergen airway epithelium airway inflammation airway obstruction airway remodeling aspirin-exacerbated respiratory disease career career development cell type curriculum development cysteinyl-leukotriene didactic education disorder control eosinophil gut microbiota inhibitor/antagonist mast cell mucosal site novel profiles in patients receptor recruit research and development respiratory response responsible research conduct skills transcription factor transcriptome transcriptome sequencing translational research program

项目摘要

PROJECT SUMMARY/ABSTRACT: This proposal details a five-year plan to provide the candidate, Lora Bankova, MD, with the knowledge and expertise to become an independent investigator in the field of Allergy and Immunology. The studies focus on a previously unrecognized role of the stable cysteinyl leukotriene (cysLT) metabolite LTE4 in the control of proximal events leading to development of type 2 immunity to the outdoor mold aeroallergen, Alternaria. Using a combination of cellular and molecular approaches, the candidate will test the hypothesis that GPR99 drives innate type 2 immunity and airway remodeling through the control of epithelial cell activation for IL-25 generation. As LTE4 is the only stable cysLT metabolite and is detected in asthma elicited by allergen, viruses, aspirin, there are significant translational implications for asthma. The short-term goals of this K08 award application are to provide training in advanced imaging techniques, advanced genomic techniques, including RNA-Seq, and human translational research. Dr. Bankova's long-term goal is to develop an independent translational research program studying the innate immune control of allergic disease. During the period of support the candidate will complement her laboratory skills with didactic coursework to develop skills in emerging gene sequencing and editing methods, courses in bioinformatics and systems biology, grant writing, leadership, and the responsible conduct of research germane to the application. This will then facilitate her transition to independence during the third and fourth years of the award. Dr. Bankova will work under the mentorship of Nora Barrett, MD and Joshua Boyce, MD, experts in cysLT biology and mechanisms of inflammation. Dr. Bankova has also assembled a team of extraordinary scientists, including Drs. Yoshihide Kanaoka, Carla Kim, Bruce Levy, Howard Katz, and K. Frank Austen, who have committed their time, resources, and expertise to facilitate her career development and research goals. Under their mentorship and guidance, in an ideal scientific environment at the Brigham and Women's Hospital, training in immunology, didactic curriculum, and career development plan will position the candidate to secure independent NIH funding and to establish herself as a physician scientist with a focus on the role of mast cells and cysLTs in instructing epithelial cell activation to guide immune bias at mucosal surfaces.

项目总结/文摘: